XML 17 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 58,459 $ 59,065
Accounts receivable, net 30,092 25,195
Inventory 41,309 38,391
Prepaid expenses and other current assets 5,921 6,254
Total current assets 135,781 128,905
Property and equipment, net 66,374 66,711
Field equipment, net 20,978 20,744
Deferred cost of revenues 34,065 33,068
Intangible assets, net 10,714 11,744
Goodwill 42,710 42,710
Other assets 3,074 2,992
Total assets 313,696 306,874
Current liabilities:    
Accounts payable 13,583 10,767
Accrued expenses 26,616 27,266
Current portion of long-term debt 324 315
Other current liabilities 4,452 4,394
Total current liabilities 44,975 42,742
Deferred revenues 52,280 51,362
Long-term debt 1,602 1,664
Other long-term liabilities 16,911 17,367
Total liabilities 115,768 113,135
Commitments and contingencies
Noncontrolling interests subject to put provisions 168 219
Stockholders’ equity:    
Undesignated preferred stock: par value $0.001, 5,000,000 shares authorized; no shares issued and outstanding as of June 30, 2016 and December 31, 2015 0 0
Common stock: par value $0.001, 100,000,000 shares authorized; 65,443,862 and 64,873,038 shares issued as of June 30, 2016 and December 31, 2015, respectively 65 64
Additional paid-in capital 621,395 612,487
Accumulated deficit (405,838) (402,830)
Accumulated other comprehensive loss (4,250) (4,031)
Treasury stock, at cost: 901,013 and 822,059 shares as of June 30, 2016 and December 31, 2015, respectively (15,334) (13,864)
Total NxStage Medical, Inc. stockholders' equity 196,038 191,826
Noncontrolling interests not subject to put provisions 1,722 1,694
Total stockholders' equity 197,760 193,520
Total liabilities and stockholders’ equity $ 313,696 $ 306,874